Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.

Ruscito I, Darb-Esfahani S, Kulbe H, Bellati F, Zizzari IG, Rahimi Koshkaki H, Napoletano C, Caserta D, Rughetti A, Kessler M, Sehouli J, Nuti M, Braicu EI.

Gynecol Oncol. 2018 May 10. pii: S0090-8258(18)30892-8. doi: 10.1016/j.ygyno.2018.05.006. [Epub ahead of print]

PMID:
29753392
2.

TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway.

Zizzari IG, Napoletano C, Botticelli A, Caponnetto S, Calabrò F, Gelibter A, Rughetti A, Ruscito I, Rahimi H, Rossi E, Schinzari G, Marchetti P, Nuti M.

Cancer Immunol Res. 2018 Apr 26. doi: 10.1158/2326-6066.CIR-17-0594. [Epub ahead of print]

PMID:
29700053
3.
4.

Anisakis pegreffii impacts differentiation and function of human dendritic cells.

Napoletano C, Mattiucci S, Colantoni A, Battisti F, Zizzari IG, Rahimi H, Nuti M, Rughetti A.

Parasite Immunol. 2018 May;40(5):e12527. doi: 10.1111/pim.12527.

PMID:
29569735
5.

Cancer immunotherapy in patients with brain metastases.

Caponnetto S, Draghi A, Borch TH, Nuti M, Cortesi E, Svane IM, Donia M.

Cancer Immunol Immunother. 2018 May;67(5):703-711. doi: 10.1007/s00262-018-2146-8. Epub 2018 Mar 8. Review.

PMID:
29520474
6.

Impact of genetically engineered maize on agronomic, environmental and toxicological traits: a meta-analysis of 21 years of field data.

Pellegrino E, Bedini S, Nuti M, Ercoli L.

Sci Rep. 2018 Feb 15;8(1):3113. doi: 10.1038/s41598-018-21284-2. Erratum in: Sci Rep. 2018 Apr 19;8(1):6485.

7.

The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

Botticelli A, Onesti CE, Zizzari I, Cerbelli B, Sciattella P, Occhipinti M, Roberto M, Di Pietro F, Bonifacino A, Ghidini M, Vici P, Pizzuti L, Napoletano C, Strigari L, D'Amati G, Mazzuca F, Nuti M, Marchetti P.

Oncotarget. 2017 Nov 1;8(59):99336-99346. doi: 10.18632/oncotarget.22242. eCollection 2017 Nov 21.

8.

Critical Limb Ischemia: A Practical Up-To-Date Review.

Fabiani I, Calogero E, Pugliese NR, Di Stefano R, Nicastro I, Buttitta F, Nuti M, Violo C, Giannini D, Morgantini A, Conte L, Barletta V, Berchiolli R, Adami D, Ferrari M, Di Bello V.

Angiology. 2017 Jan 1:3319717739387. doi: 10.1177/0003319717739387. [Epub ahead of print]

PMID:
29161885
9.

Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells.

Battisti F, Napoletano C, Rahimi Koshkaki H, Belleudi F, Zizzari IG, Ruscito I, Palchetti S, Bellati F, Benedetti Panici P, Torrisi MR, Caracciolo G, Altieri F, Nuti M, Rughetti A.

Front Immunol. 2017 Sep 25;8:1179. doi: 10.3389/fimmu.2017.01179. eCollection 2017.

10.

Response to Kruse-Plass et al. (2017) regarding the risk to non-target lepidopteran larvae exposed to pollen from one or more of three Bt maize events (MON810, Bt11 and 1507).

Perry JN, Barberi P, Bartsch D, Birch ANE, Gathmann A, Kiss J, Manachini B, Nuti M, Rauschen S, Schiemann J, Schuppener M, Sweet J, Tebbe CC, Veronesi F.

Environ Sci Eur. 2017;29(1):21. doi: 10.1186/s12302-017-0119-8. Epub 2017 May 10.

11.

Assessing environmental impacts of genetically modified plants on non-target organisms: The relevance of in planta studies.

Arpaia S, Birch ANE, Kiss J, van Loon JJA, Messéan A, Nuti M, Perry JN, Sweet JB, Tebbe CC.

Sci Total Environ. 2017 Apr 1;583:123-132. doi: 10.1016/j.scitotenv.2017.01.039. Epub 2017 Jan 15. Review.

PMID:
28095991
12.

Long-term survival of patients with critical limb ischemia treated with iloprost: response rate and predictive criteria. A retrospective analysis of 102 patients.

Melillo E, Lucaccini E, Berchiolli R, Adami D, Nuti M, Dell'Omo G, Farina A, Panigada G, Roberts AT, Meini S.

Eur Rev Med Pharmacol Sci. 2016 Dec;20(24):5233-5241.

13.

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment.

Botticelli A, Zizzari I, Mazzuca F, Ascierto PA, Putignani L, Marchetti L, Napoletano C, Nuti M, Marchetti P.

Oncotarget. 2017 Jan 31;8(5):8890-8899. doi: 10.18632/oncotarget.12985. Review.

14.

Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing Cells.

Napoletano C, Bellati F, Ruscito I, Pernice M, Zizzari IG, Caponnetto S, Tomao F, Frigerio L, Liberati M, Rughetti A, Caserta D, Panici PB, Nuti M.

Anticancer Res. 2016 Oct;36(10):5109-5116.

PMID:
27798870
15.

Long-term clinical outcomes in critical limb ischemia--A retrospective study of 181 patients.

Melillo E, Micheletti L, Nuti M, Dell'Omo G, Berchiolli R, Adami D, Farina A, Panigada G, Meini S.

Eur Rev Med Pharmacol Sci. 2016;20(3):502-8.

16.

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial.

Antonilli M, Rahimi H, Visconti V, Napoletano C, Ruscito I, Zizzari IG, Caponnetto S, Barchiesi G, Iadarola R, Pierelli L, Rughetti A, Bellati F, Panici PB, Nuti M.

Int J Oncol. 2016 Apr;48(4):1369-78. doi: 10.3892/ijo.2016.3386. Epub 2016 Feb 8.

17.

MGL Receptor and Immunity: When the Ligand Can Make the Difference.

Zizzari IG, Napoletano C, Battisti F, Rahimi H, Caponnetto S, Pierelli L, Nuti M, Rughetti A.

J Immunol Res. 2015;2015:450695. doi: 10.1155/2015/450695. Epub 2015 Dec 29. Review.

18.

The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions.

Zizzari IG, Martufi P, Battisti F, Rahimi H, Caponnetto S, Bellati F, Nuti M, Rughetti A, Napoletano C.

PLoS One. 2015 Jul 6;10(7):e0132617. doi: 10.1371/journal.pone.0132617. eCollection 2015.

19.

Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis.

Cardinale V, Carpino G, Gentile R, Napoletano C, Rahimi H, Franchitto A, Semeraro R, Nuti M, Onori P, Berloco PB, Rossi M, Bosco D, Brunelli R, Fraveto A, Napoli C, Torrice A, Gatto M, Venere R, Bastianelli C, Aliberti C, Salvatori FM, Bresadola L, Bezzi M, Attili AF, Reid L, Gaudio E, Alvaro D.

BMC Gastroenterol. 2014 Dec 4;14:204. doi: 10.1186/s12876-014-0204-z.

20.

Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost.

Melillo E, Grigoratos C, Sanctis FD, Spontoni P, Nuti M, Dell'Omodarme M, Ferrari M, Balbarini A.

Angiology. 2015 Jul;66(6):531-8. doi: 10.1177/0003319714541800. Epub 2014 Jul 8.

PMID:
25005765
21.

Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing.

Rughetti A, Rahimi H, Belleudi F, Napoletano C, Battisti F, Zizzari IG, Antonilli M, Bellati F, Wandall HH, Benedetti Panici P, Burchell JM, Torrisi MR, Nuti M.

Cancer Immunol Res. 2014 Feb;2(2):177-86. doi: 10.1158/2326-6066.CIR-13-0112-T. Epub 2013 Oct 28.

22.

Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder.

Carpino G, Cardinale V, Gentile R, Onori P, Semeraro R, Franchitto A, Wang Y, Bosco D, Iossa A, Napoletano C, Cantafora A, D'Argenio G, Nuti M, Caporaso N, Berloco P, Venere R, Oikawa T, Reid L, Alvaro D, Gaudio E.

J Hepatol. 2014 Jun;60(6):1194-202. doi: 10.1016/j.jhep.2014.01.026. Epub 2014 Feb 13.

PMID:
24530598
23.

Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells.

Iudicone P, Fioravanti D, Bonanno G, Miceli M, Lavorino C, Totta P, Frati L, Nuti M, Pierelli L.

J Transl Med. 2014 Jan 27;12:28. doi: 10.1186/1479-5876-12-28.

24.

Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells.

Paroli M, Bellati F, Videtta M, Focaccetti C, Mancone C, Donato T, Antonilli M, Perniola G, Accapezzato D, Napoletano C, Nuti M, Bartolazzi A, Panici PB, Tripodi M, Palombo F, Barnaba V.

Int J Cancer. 2014 Apr 15;134(8):1823-34. doi: 10.1002/ijc.28515. Epub 2013 Oct 22. Erratum in: Int J Cancer. 2014 Jul 15;135(2):E1.

25.

Microbially-enhanced composting of olive mill solid waste (wet husk): bacterial and fungal community dynamics at industrial pilot and farm level.

Agnolucci M, Cristani C, Battini F, Palla M, Cardelli R, Saviozzi A, Nuti M.

Bioresour Technol. 2013 Apr;134:10-6. doi: 10.1016/j.biortech.2013.02.022. Epub 2013 Feb 16.

PMID:
23500553
26.

Exposure to extreme climatic environments reduces circulating endothelial progenitor cells.

Felice F, Dal Monte M, Di Stefano R, Bagnoli P, Michi P, Nuti M, Balbarini A.

Int J Cardiol. 2013 Sep 20;168(1):621-2. doi: 10.1016/j.ijcard.2013.01.202. Epub 2013 Mar 7. No abstract available.

PMID:
23465243
27.

Interaction between Treg cells and angiogenesis: a dark double track.

Gasparri ML, Bellati F, Napoletano C, Panici PB, Nuti M.

Int J Cancer. 2013 May 15;132(10):2469. doi: 10.1002/ijc.27920. Epub 2012 Nov 20. No abstract available.

28.

Past, present and future strategies of immunotherapy in gynecological malignancies.

Bellati F, Napoletano C, Ruscito I, Visconti V, Antonilli M, Gasparri ML, Zizzari IG, Rahimi H, Palaia I, Rughetti A, Benedetti Panici P, Nuti M.

Curr Mol Med. 2013 May;13(4):648-69.

PMID:
22934850
29.

Lack of a relationship between circulating gamma-glutamyltransferase levels and carotid intima media thickness in hypertensive and diabetic patients.

Nuti M, Spontoni P, Grigoratos C, Dell'Omo G, Balbarini A, Pedrinelli R.

Vasc Health Risk Manag. 2012;8:275-81. doi: 10.2147/VHRM.S30747. Epub 2012 May 1.

30.

Response to "The anglerfish deception".

Perry JN, Arpaia S, Bartsch D, Kiss J, Messéan A, Nuti M, Sweet JB, Tebbe CC.

EMBO Rep. 2012 Jun 1;13(6):481-2; author reply 482-3. doi: 10.1038/embor.2012.70. No abstract available.

31.

Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol.

Rutella S, Iudicone P, Bonanno G, Fioravanti D, Procoli A, Lavorino C, Foddai ML, Lorusso D, Martinelli E, Vacca M, Ipsevich F, Nuti M, Scambia G, Pierelli L.

Cytotherapy. 2012 Aug;14(7):841-50. doi: 10.3109/14653249.2012.681038. Epub 2012 May 7.

PMID:
22563888
32.

Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.

Napoletano C, Zizzari IG, Rughetti A, Rahimi H, Irimura T, Clausen H, Wandall HH, Belleudi F, Bellati F, Pierelli L, Frati L, Nuti M.

Eur J Immunol. 2012 Apr;42(4):936-45. doi: 10.1002/eji.201142086.

33.

Estimating the effects of Cry1F Bt-maize pollen on non-target Lepidoptera using a mathematical model of exposure.

Perry JN, Devos Y, Arpaia S, Bartsch D, Ehlert C, Gathmann A, Hails RS, Hendriksen NB, Kiss J, Messéan A, Mestdagh S, Neemann G, Nuti M, Sweet JB, Tebbe CC.

J Appl Ecol. 2012 Feb;49(1):29-37.

34.

Monoclonal antibodies in gynecological cancer: a critical point of view.

Bellati F, Napoletano C, Gasparri ML, Visconti V, Zizzari IG, Ruscito I, Caccetta J, Rughetti A, Benedetti-Panici P, Nuti M.

Clin Dev Immunol. 2011;2011:890758. doi: 10.1155/2011/890758. Epub 2011 Dec 26. Review.

35.

Microbially-enhanced composting of wet olive husks.

Echeverria MC, Cardelli R, Bedini S, Colombini A, Incrocci L, Castagna A, Agnolucci M, Cristani C, Ranieri A, Saviozzi A, Nuti M.

Bioresour Technol. 2012 Jan;104:509-17. doi: 10.1016/j.biortech.2011.11.042. Epub 2011 Nov 23.

PMID:
22154749
36.

Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms.

Bellati F, Napoletano C, Gasparri ML, Ruscito I, Marchetti C, Pignata S, Tomao F, Benedetti Panici P, Nuti M.

Crit Rev Oncol Hematol. 2012 Jul;83(1):35-46. doi: 10.1016/j.critrevonc.2011.09.006. Epub 2011 Nov 4. Review.

PMID:
22056314
37.

Counting of leukocytes in samples from G-CSF mobilized donors, leukapheresis products, and cord blood: the performances of an analyzer with dedicated profiles.

Pierelli L, Fioravanti D, Patti D, Iudicone P, Scocchera R, Pandolfi A, Nuti M.

Int J Lab Hematol. 2012 Apr;34(2):154-63. doi: 10.1111/j.1751-553X.2011.01373.x. Epub 2011 Sep 6.

PMID:
21895988
38.

Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimens.

Marchetti C, Bellati F, Musella A, Napoletano C, Perniola G, Di Donato V, Pignata S, Nuti M, Panici PB.

Int J Clin Oncol. 2012 Aug;17(4):385-9. doi: 10.1007/s10147-011-0300-9. Epub 2011 Sep 3.

PMID:
21892670
39.

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.

Zizzari IG, Veglia F, Taurino F, Rahimi H, Quaglino E, Belleudi F, Riccardo F, Antonilli M, Napoletano C, Bellati F, Benedetti-Panici P, Torrisi MR, Frati L, Nuti M, Rughetti A.

J Mol Med (Berl). 2011 Dec;89(12):1231-40. doi: 10.1007/s00109-011-0794-7. Epub 2011 Aug 16.

40.

Immune effects of trastuzumab.

Nuti M, Bellati F, Visconti V, Napoletano C, Domenici L, Caccetta J, Zizzari IG, Ruscito I, Rahimi H, Benedetti-Panici P, Rughetti A.

J Cancer. 2011;2:317-23. Epub 2011 May 25.

41.

Asymptomatic aneurysm of the superior mesenteric artery: a time bomb.

Spontoni P, Venturini M, De Sanctis F, Grigoratos C, Nuti M, Coppi G, Faggioni L, Chiesa R, Balbarini A.

J Cardiovasc Med (Hagerstown). 2011 Aug;12(8):589-91. doi: 10.2459/JCM.0b013e328347580c. No abstract available.

PMID:
21558871
42.

Sulphur dioxide affects culturability and volatile phenol production by Brettanomyces/Dekkera bruxellensis.

Agnolucci M, Rea F, Sbrana C, Cristani C, Fracassetti D, Tirelli A, Nuti M.

Int J Food Microbiol. 2010 Sep 30;143(1-2):76-80. doi: 10.1016/j.ijfoodmicro.2010.07.022. Epub 2010 Jul 27.

PMID:
20705352
43.

Immunologic systemic effect of neoadjuvant chemotherapy requires investigation before tumor-associated lymphocytes can be introduced in breast cancer treatment algorithm.

Bellati F, Napoletano C, Gasparri ML, Panici PB, Nuti M.

J Clin Oncol. 2010 Sep 20;28(27):e471-2; author reply e473. doi: 10.1200/JCO.2010.27.9984. Epub 2010 Jun 28. No abstract available.

PMID:
20585098
44.

Cellular adaptive immune system plays a crucial role in trastuzumab clinical efficacy.

Bellati F, Napoletano C, Ruscito I, Liberati M, Panici PB, Nuti M.

J Clin Oncol. 2010 Jul 20;28(21):e369-70; author reply e371. doi: 10.1200/JCO.2010.28.6922. Epub 2010 May 17. No abstract available.

PMID:
20479394
45.

Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review.

Bellati F, Napoletano C, Ruscito I, Pastore M, Pernice M, Antonilli M, Nuti M, Benedetti Panici P.

Invest New Drugs. 2010 Dec;28(6):887-94. doi: 10.1007/s10637-009-9351-4. Epub 2009 Nov 24. Review.

PMID:
19936983
46.

Obsessive-Compulsive and Post Traumatic Avoidance Symptoms Influence the Response to Antihypertensive Therapy: Relevance in Uncontrolled Hypertension.

Realdi A, Favaro A, Santonastaso P, Nuti M, Parotto E, Inverso G, Leoni M, Macchini L, Vettore F, Calo L, Semplicini A.

Pharmaceuticals (Basel). 2009 Nov 16;2(3):82-93.

47.

Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy.

Napoletano C, Rughetti A, Landi R, Pinto D, Bellati F, Rahimi H, Spinelli GP, Pauselli S, Sale P, Dolo V, De Lorenzo F, Tomao F, Benedetti-Panici P, Frati L, Nuti M.

Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):647-58.

PMID:
19822081
48.

Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression.

Napoletano C, Bellati F, Landi R, Pauselli S, Marchetti C, Visconti V, Sale P, Liberati M, Rughetti A, Frati L, Panici PB, Nuti M.

J Cell Mol Med. 2010 Dec;14(12):2748-59. doi: 10.1111/j.1582-4934.2009.00911.x.

49.

HPV induced triple neoplasms: a case report.

Visconti V, Antonilli M, Bellati F, Napoletano C, French D, Benedetti Panici P, Nuti M.

Am J Obstet Gynecol. 2009 Aug;201(2):e9-e12. doi: 10.1016/j.ajog.2009.05.008.

PMID:
19646562
50.

HAS-1 genetic polymorphism in sporadic abdominal aortic aneurysm.

Armani C, Landi S, Nuti M, Di Stefano R, Balbarini A.

Heart Int. 2009 Jun 30;4(1):e1. doi: 10.4081/hi.2009.e1.

Supplemental Content

Support Center